RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Manish Patel, DO
University of Minnesota, Division of Hematology, Oncology and Transplantation
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Dr. Amit Kulkarni
Phoenix, Arizona, United States
Not, yet, recruiting - Mncctn Essentia Health St. Joseph'S Brainerd Medical Center
Brainerd, Minnesota, United States
Recruiting - Mncctn Essentia Health Deer River
Deer River, Minnesota, United States
Recruiting - Mncctn Essentia Health St. Mary'S Detroit Lakes Clinic
Detroit Lakes, Minnesota, United States
Recruiting - Mncctn Essentia Health Duluth
Duluth, Minnesota, United States
Recruiting - Mncctn Essentia Health Fosston
Fosston, Minnesota, United States
Recruiting - Mncctn Essentia Health Hibbing Clinic
Hibbing, Minnesota, United States
Recruiting - Masonic Cancer Center, University of Minnesota
Minneapolis, Minnesota, United States
Recruiting - Mncctn Essentia Health Sandstone
Sandstone, Minnesota, United States
Recruiting - Mncctn Essentia Health Virginia Clinic
Virginia, Minnesota, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2022
- Primary completion
- 31 Jan 2028
- Completion
- 31 Jan 2028
- Last update posted
- 11 Sept 2025
- Registered enrollment
- 82
- Registry id
- NCT04105270
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.